Linkage of clinical trial and administrative data: a survey of cancer patient preferences

Current oncology

Y.W. Leung¹  C. Tian²  M.C. Brown³  A.E. Hay³  D. Howell⁴  G. Liu⁵  J.L. Pater⁶  E. Bell⁷  Z. Kassam⁷  S. Willing⁷ 

[1] Queen’s University;Southlake Regional Health Centre;Canadian Cancer Trials Group;Clinical Trials Ontario;Kingston General Hospital;Princess Margaret Cancer Centre;University Hospital Network

关键词: Survey;    clinical trials;    consent;    data linkage;   

DOI  :  10.3747/co.24.3400

学科分类：肿瘤学

来源: Multimed, Inc.

【 摘 要 】

BackgroundPersonal health information, including diagnoses and hospital admissions, is routinely collected in administrative databases. Patients enrolling on clinical trials consent to separate collection and storage of their personal health information. We evaluated patient preferences for linking long-term data from administrative databases with clinical trials. MethodsAdults with cancer attending outpatient clinics at 3 Ontario hospitals were surveyed about their willingness, when faced with the hypothetical scenario of participating in a clinical trial, to provide potentially identifying information such as initials and date of birth to facilitate long-term research access to normally deidentified publicly collected databases. Results Of 569 patients surveyed, 335 (59%) were women, 452 (79%) were white, 385 (68%) had a post-secondary education, and 386 (68%) had never participated in a clinical trial. Median age in the group was 59 years. Most participants (93%, cohort 1) would allow long-term access to their information and allow personal information to be used to match clinical trial with administrative data. At the time of clinical trial closure, two thirds of participants (68%, cohort 2) preferred to make additional clinical information available through linkage with administrative databases, and 8 (9%) preferred to have no further information made available to researchers. No significant differences were found in the subset of patients who were part of a clinical trial and those who had never participated ( p= 0.65). InterpretationAlmost all patients would allow a clinical trial research team to access their confidential information, providing a more comprehensive assessment of an intervention’s long-term risks and benefits.

【 授权许可】

Unknown